Bandyopadhyay, Soham http://orcid.org/0000-0001-6553-3842
Schwendinger, Nina
Jahromi, Behnam Rezai http://orcid.org/0000-0003-3937-2816
Lad, Shivanand P. http://orcid.org/0000-0003-4991-5319
Blackburn, Spiros http://orcid.org/0000-0003-2902-5079
Wolf, Stefan http://orcid.org/0000-0002-3563-3954
Bulters, Diederik http://orcid.org/0000-0001-9884-9050
Galea, Ian http://orcid.org/0000-0002-1268-5102
Hugelshofer, Michael http://orcid.org/0000-0002-3057-0472
Funding for this research was provided by:
National Institute for Health and Care Research (ACF-2022-26-004)
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 29 December 2023
Revised: 14 February 2024
Accepted: 15 February 2024
First Online: 29 February 2024
Declarations
:
: Not applicable.
: IG and DB declare research funding and consulting fees from BioProducts Laboratory Limited and Evgen Pharma. IG received research funding related to haptoglobin from the Medical Research Council and Engineering and Physical Sciences Research Council. IG and MH disclose consulting fees from CSL Behring. MH received research funding from CSL Behring and is an inventor on a patent related to the use of haptoglobin. BRJ received a grant to run the ARCH trial and has patents pending on CSF exchange.